ValiRx plc (LON:VAL – Get Free Report) shares shot up 5.6% during mid-day trading on Monday . The stock traded as high as GBX 0.36 and last traded at GBX 0.36. 13,996,284 shares traded hands during trading, an increase of 95% from the average session volume of 7,178,194 shares. The stock had previously closed at GBX 0.34.
ValiRx Stock Up 28.7%
The company has a quick ratio of 1.27, a current ratio of 6.65 and a debt-to-equity ratio of 0.44. The firm’s 50-day moving average price is GBX 0.36 and its 200 day moving average price is GBX 0.51. The firm has a market cap of £3.23 million, a P/E ratio of -0.47 and a beta of 0.59.
ValiRx (LON:VAL – Get Free Report) last posted its earnings results on Monday, September 29th. The company reported GBX (0.22) earnings per share (EPS) for the quarter. ValiRx had a negative net margin of 20,554.01% and a negative return on equity of 55.84%. As a group, research analysts expect that ValiRx plc will post -1.74 earnings per share for the current year.
About ValiRx
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Further Reading
- Five stocks we like better than ValiRx
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Is Tesla Overvalued? 2 Reasons It Might Be a Bargain
- Investing in Commodities: What Are They? How to Invest in Them
- How These 2 Stocks Won 2025’s AI Race—And What’s In Store for 2026
- What is a support level?
- Intel Snaps Up AI Tech for Pennies on the Dollar
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
